Somatostatin Receptor Imaging with [<sup>18</sup>F]FET-βAG-TOCA PET/CT and [<sup>68</sup>Ga]Ga-DOTA-Peptide PET/CT in Patients with Neuroendocrine Tumors: A Prospective, Phase 2 Comparative Study-Reference-Cited by-同舟云学术

Somatostatin Receptor Imaging with [¹⁸F]FET-βAG-TOCA PET/CT and [⁶⁸Ga]Ga-DOTA-Peptide PET/CT in Patients with Neuroendocrine Tumors: A Prospective, Phase 2 Comparative Study

Published:2024-02-08 Issue:3 Volume:65 Page:416-422
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Dubash Suraiya,Barwick Tara D.,Kozlowski Kasia,Rockall Andrea G.,Khan Sairah,Khan Sameer,Yusuf Siraj,Lamarca Angela,Valle Juan W.,Hubner Richard A.,McNamara Mairéad G.,Frilling Andrea,Tan Tricia,Wernig Florian,Todd Jeannie,Meeran Karim,Pratap Bhavesh,Azeem Saleem,Huiban Michael,Keat Nicholas,Lozano-Kuehne Jingky P.,Aboagye Eric O.,Sharma Rohini

Publisher

Society of Nuclear Medicine

Reference18 articles.

1. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2. One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States

3. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Towards a Standardized Approach to the Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors and Their Prognostic Stratification

4. Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites

5. 68Ga-DOTA-NOC PET/CT Imaging of Neuroendocrine Tumors: Comparison with 111In-DTPA-Octreotide (OctreoScan®)

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiolabeled Somatostatin Analogs for Cancer Imaging;Seminars in Nuclear Medicine;2024-08

2. Evaluation of the safety, biodistribution, dosimetry of [18F]AlF-NOTA-LM3 and head-to-head comparison with [68Ga]Ga-DOTATATE in patients with well-differentiated neuroendocrine tumors: an interim analysis of a prospective trial;European Journal of Nuclear Medicine and Molecular Imaging;2024-06-15